Mild-to-Moderate Hypertriglyceridemia Leads to Acute Pancreatitis
|
By LabMedica International staff writers Posted on 23 Nov 2016 |

Image: A histopathology of acute pancreatitis showing hemorrhage, parenchymal necrosis, and fat necrosis (Photo courtesy of Kathryn Lindsey, MD).
Pancreatitis is very painful and it may lead to fatalities and until now, medical science has connected the risk of developing this illness to gallstone, a high intake of alcohol and very high concentrations of blood fats or triglycerides.
Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.
Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.
The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.
Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.
Related Links:
Copenhagen University Hospital
Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.
Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.
The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.
Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.
Related Links:
Copenhagen University Hospital
Latest Clinical Chem. News
- New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
- Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
- Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
- Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
Channels
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







